ConductScience.org, home

Paper40723909

Emerging Molecular Mechanisms in Malaria Pathogenesis and Novel Therapeutic Approaches: A Focus on P. falciparum Malaria.

Sanyaolu A and 9 others. Biomolecules, 2025. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Emerging Molecular Mechanisms in Malaria Pathogenesis and Novel Therapeutic Approaches: A Focus on P. falciparum Malaria. Papers, record 40723909. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40723909

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Emerging Molecular Mechanisms in Malaria Pathogenesis and Novel Therapeutic Approaches: A Focus on P. falciparum Malaria.
PubMed
Journal
Biomolecules
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.67, provisional
iCite
Revised in PubMed
2026-03-31
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sanyaolu AAdekunlehttps://orcid.org/0000-0002-6265-665X
2Marinkovic AAleksandrahttps://orcid.org/0000-0002-3672-0777
3Prakash SStephanie
4Balendra VVyshnavyhttps://orcid.org/0000-0002-9502-0885
5Shazley OOmarhttps://orcid.org/0000-0003-3456-3111
6Gardellini TTatianahttps://orcid.org/0009-0009-1591-874X
7Jan AAbdul
8Younis KKokab
9Okorie CChukuhttps://orcid.org/0000-0001-5483-0032
10Izurieta RRicardo

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Malaria, FalciparumMajor topic
Plasmodium falciparumMajor topic
Humans
Antimalarials
Malaria Vaccines
Animals
Drug Resistance

Source PubMed

Download CSV of topics

References183

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139448626Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates.NPJ Vaccines2024https://conductscience.org/library/papers/39448626PubMed
239565990Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite.N Engl J Med2024https://conductscience.org/library/papers/39565990PubMed
335456085The Dangerous Liaisons in the Oxidative Stress Response to Leishmania Infection.Pathogens2022https://conductscience.org/library/papers/35456085PubMed
419157883Synthetic medicinal chemistry of selected antimalarial natural products.Bioorg Med Chem2009https://conductscience.org/library/papers/19157883PubMed
529052917Post-translational modifications as key regulators of apicomplexan biology: insights from proteome-wide studies.Mol Microbiol2018https://conductscience.org/library/papers/29052917PubMed
637652975Antimalarial drug discovery: progress and approaches.Nat Rev Drug Discov2023https://conductscience.org/library/papers/37652975PubMed
730596732Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review.PLoS One2018https://conductscience.org/library/papers/30596732PubMed
838341502Establishing RTS,S/AS01 as a benchmark for comparison to next-generation malaria vaccines in a mouse model.NPJ Vaccines2024https://conductscience.org/library/papers/38341502PubMed
940274841PfRH5 vaccine; from the bench to the vial.NPJ Vaccines2025https://conductscience.org/library/papers/40274841PubMed
1021035841Operational strategies to achieve and maintain malaria elimination.Lancet2010https://conductscience.org/library/papers/21035841PubMed
1125965399Setting international standards for the management of public health pesticides.PLoS Med2015https://conductscience.org/library/papers/25965399PubMed
1234977998Antimalarial Natural Products.Prog Chem Org Nat Prod2022https://conductscience.org/library/papers/34977998PubMed
1321623767Malaria: modification of the red blood cell and consequences in the human host.Br J Haematol2011https://conductscience.org/library/papers/21623767PubMed
1438656211Vaccines and monoclonal antibodies: new tools for malaria control.Clin Microbiol Rev2024https://conductscience.org/library/papers/38656211PubMed
1539407740Global Fight against Malaria: Goals and Achievements 1900-2022.J Clin Med2024https://conductscience.org/library/papers/39407740PubMed
1625502316Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance.Science2015https://conductscience.org/library/papers/25502316PubMed
1733964223Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.Lancet2021https://conductscience.org/library/papers/33964223PubMed
1840234440Recent perspectives in clinical development of malaria vaccines.Nat Commun2025https://conductscience.org/library/papers/40234440PubMed
1937327809
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Lancet Infect Dis2023https://conductscience.org/library/papers/37327809PubMed
2038982498Examining geographical inequalities for malaria outcomes and spending on malaria in 40 malaria-endemic countries, 2010-2020.Malar J2024https://conductscience.org/library/papers/38982498PubMed

See all 183 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42848841Manipulation of host response and trajectory of parasite survival: A damage-response framework perspective.Virulence2026https://conductscience.org/library/papers/42848841PubMed
42515022Dual Functions of Polyamines in Shaping Host-Specific Pathogen Dynamics.Pathogens2026https://conductscience.org/library/papers/42515022PubMed
42467713Complement evasion by apicomplexans: Convergent strategies across diverse parasites.PLoS Pathog2026https://conductscience.org/library/papers/42467713PubMed
42356575In Vitro, In Silico, and In Vivo Evaluation of Antiplasmodial Activity of Ursodeoxycholic Acid Following GNPS Dereplication of an Active Streptomyces sp. Fraction.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42356575PubMed
42226746Hepatorenal protective role of encapsulated Holothuria atra in a mice model of Plasmodium berghei ANKA inoculation.J Adv Vet Anim Res2026https://conductscience.org/library/papers/42226746PubMed
41972578Malaria in the 21st Century: Global Disease Burden, Epidemiological Insights, and Strategic Control Approaches.Biology (Basel)2026https://conductscience.org/library/papers/41972578PubMed
41888692Incidence of kelch13 and Pfmdr1 gene mutations associated with antimalarial drug resistance in Plasmodium falciparum isolates from Ethiopia: a systematic review and meta-analysis.BMC Infect Dis2026https://conductscience.org/library/papers/41888692PubMed
41524916The symbiotic Wolbachia in Anopheles and its role in reducing the transmission of Plasmodium: updates and prospects.Arch Microbiol2026https://conductscience.org/library/papers/41524916PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40723909

GET https://conductscience.org/api/papers/v1/40723909/references?page=2